Sponsor hub
Imperial College London clinical trial failures
Review 34 stopped clinical trials from Imperial College London, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 22
- OTHER/UNKNOWN
- 12
Notable sponsors
- Imperial College London
- 34
Related phases
- Phase II
- 9
- Phase IV
- 9
- Unknown
- 7
- Phase I
- 4
- Phase III
- 4
Crawlable stopped-trial records
Open ExploreShowing up to 34 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Neuroendocrine Tumor G1 (NET G1)/Carcinoid trial by Imperial College London. Stop reason: OPERATIONAL.
The study has closed earlier than planned due to one of the funders decision to withdraw the financial support for the study.
Phase II Breast Cancer trial by Imperial College London. Stop reason: OPERATIONAL.
Study was stopped because funder pulled funding for the study. 2 patients were screened however none of the screen patients were eventually recruited
Unknown Varicose Veins trial by Imperial College London. Stop reason: OPERATIONAL.
Very poor recruitment
Phase III Kidney Transplant Rejection trial by Imperial College London. Stop reason: OPERATIONAL.
Stopped at start of COVID-19 pandemic - non-feasible
Phase II Breast Cancer trial by Imperial College London. Stop reason: OPERATIONAL.
Slow patient recruitment
Phase IV Coronary Artery Disease trial by Imperial College London. Stop reason: OPERATIONAL.
Funding withdrawn
Phase IV Mixed Urinary Incontinence trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
it stopped at a regulatory stage
Phase I Acute Stroke trial by Imperial College London. Stop reason: OPERATIONAL.
No financial support
Phase I Antiphospholipid Syndrome trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Literature highlighted unnecessary side effects from the relevant combination.
Unknown COPD trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Diabetic Macular Edema trial by Imperial College London. Stop reason: OPERATIONAL.
Funder withdrawn funding.
Phase III Cardiovascular Disease trial by Imperial College London. Stop reason: OPERATIONAL.
Funding never attained
Unknown Hereditary Haemorrhagic Telangiectasia trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Technical issues with availability of relevant personnel
Phase II Chronic Heart Failure trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Early termination following Trial Steering Committee recommendation
Unknown COVID-19 trial by Imperial College London. Stop reason: OPERATIONAL.
Difficulty in recruiting eligible participants
Phase I Obesity trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Expected PK\&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy
Phase III Glaucoma trial by Imperial College London. Stop reason: OPERATIONAL.
suspended due to COVID
Unknown Prostate Cancer trial by Imperial College London. Stop reason: OPERATIONAL.
No one recruited due to resource limitations. Issues with how complicated the study could be for patients so the study was later modified and turned into a different study.
Phase IV Nonalcoholic Fatty Liver Disease trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Primary endpoint data review concluded no further patients required.
Early Phase I Alzheimer Disease trial by Imperial College London. Stop reason: OPERATIONAL.
Patient recruitment issues.
Unknown Diabetes Mellitus, Type 2 trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Data were published that superseded this study.
Phase II Short Bowel Syndrome trial by Imperial College London. Stop reason: OPERATIONAL.
No participants recruited. Not able to recruit due to COVID 19.
Phase II Pulmonary Disease, Chronic Obstructive trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Asthma trial by Imperial College London. Stop reason: OPERATIONAL.
The study was withdrawn for administrative reasons
Phase IV HIV Infections trial by Imperial College London. Stop reason: OPERATIONAL.
Recruitment problem
Phase IV Myocardial Infarction trial by Imperial College London. Stop reason: OPERATIONAL.
Changes in funding decision
Unknown Neurodegenerative Disorders trial by Imperial College London. Stop reason: OPERATIONAL.
No subjects recruited
Phase IV Cough trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Study has not been able to start due to difficulty in obtaining an intravenous formulation of cyclodextrin (intravenous 2HPBCD) suitable for man
Phase III Systemic Lupus Erythematosus, Lupus Nephritis trial by Imperial College London. Stop reason: OPERATIONAL.
Study assessments for patients recruited continuing per protocol so patients receive a minimum of 6 months follow up. No safety concerns have been raised.
Phase II Breast Neoplasms trial by Imperial College London. Stop reason: OPERATIONAL.
Recruitment challenging: lack of suitable pts; recruiting so soon after diagnosis; competing studies. Funding ended despite extensions to grant.
Phase IV Crohn's Disease trial by Imperial College London. Stop reason: OPERATIONAL.
Unable to recruit adequate trial participants
Phase II ANCA-associated Vasculitis trial by Imperial College London. Stop reason: OPERATIONAL.
Funders withdrew funding due to slow recruitment
Phase I Rheumatoid Arthritis trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
Due to unforeseen circumstances this study will not now start.
Phase IV HIV trial by Imperial College London. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.